Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 40,930 | 17,373 | N/A |
| Receivables | 1,494 | 1,354 | N/A |
| TOTAL | $43,540 | $19,224 | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,171 | 1,302 | N/A |
| Other Non-Current Assets | 0 | 1,068 | 0 |
| TOTAL | $1,171 | $2,370 | $N/A |
| Total Assets | $44,711 | $21,594 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,971 | 806 | 0 |
| Accrued Expenses | 1,549 | 1,165 | N/A |
| TOTAL | $9,332 | $11,068 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 10,734 | 10,951 | N/A |
| Deferred Revenues | 5,574 | 7,243 | N/A |
| Other Non-Current Liabilities | 163 | 464 | 0 |
| TOTAL | $10,897 | $16,465 | $N/A |
| Total Liabilities | $20,229 | $27,533 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 2,049 | N/A | N/A |
| Retained earnings | -106,630 | -84,422 | N/A |
| Other shareholders' equity | -683 | -667 | 0 |
| TOTAL | $24,482 | $-5,939 | $N/A |
| Total Liabilities And Equity | $44,711 | $21,594 | $0 |